Ondansetron Hydrochloride

盐酸昂丹司琼

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameOndansetron Hydrochloride
Drug Alias Name盐酸恩丹西酮Ondansetronum Hydrochloride奥坦西隆盐酸奥达色隆昂旦司琼盐酸盐 +[25] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsChemotherapy-induced nausea and vomitingSolid tumoursObsessive-Compulsive Disorder +[41] 
Global Approved IndicationsChemotherapy-induced nausea and vomitingVomitingNausea +[4] 
Approved Indications in ChinaVomitingNauseaPostoperative Nausea and Vomiting
Original Approved Country/TerritoryUnited States
Original Approved Date1991/01/04
Country/TerritoryCanadaUnited StatesMexico +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesCentre Integre Universitaire De Sante Et Services Sociaux Du Nord De L'Ile De MontrealGenuine Research Center, EgyptBoudicca Dx LLC +[12] 
Inactive CompaniesHamad Medical CorporationUniversity of AthensGlaxosmithkline Plc +[30] 
Active IndicationsVomitingNauseaDyspepsia +[15] 
Inactive IndicationsChemotherapy-induced nausea and vomitingSolid tumoursObsessive-Compulsive Disorder +[26] 

Other Information

ATC CodeA04AA01
Related LinksWikipediaDrugBankKEGG